Equibles does not estimate personal net worth.
Get an email with a short summary when Takeda Pharmaceutical Co Ltd publishes a filing, an earnings call transcript or a press release.
Get TAK alertsMilano Furuta is recorded as CFO at Takeda Pharmaceutical Co Ltd (TAK). Milano Furuta has spoken on 3 earnings calls across 1 company, most recently for Takeda Pharmaceutical Co Ltd on July 30, 2026. Takeda Pharmaceutical Co Ltd is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“No, thank you, Julie, and thanks, and Steve. So in Horizon 1, as Julie mentioned, there's like a big driver is, of course, in the new launches of these three assets.”
“In fiscal year 2025, we delivered solid financial results, despite a year of significant violence generic erosion. Core revenue was just over 4.5 trillion yen, with a decline of 2.6% at constant exchange rate, or CR.”
“No, thank you, Julie, and thanks, and Steve. So in Horizon 1, as Julie mentioned, there's like a big driver is, of course, in the new launches of these three assets.”
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
